The last patient showed a loss of expression of the MSH2 protein in the tumor and in non-neoplastic cells despite having a homozygous MSH6 likely pathogenic variant and an ultra-hypermutated tumor possibly through the destabilization of the heterodimer with MSH6 (Table 1). The gene discussed is MSH2; the disease is neoplasm.